Generation of Transgene-Free Lung Disease-Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette

Author:

Somers Aba12,Jean Jyh-Chang12,Sommer Cesar A.3,Omari Amel12,Ford Christopher C.12,Mills Jason A.4,Ying Lei4,Sommer Andreia Gianotti3,Jean Jenny M.1,Smith Brenden W.5,Lafyatis Robert6,Demierre Marie-France7,Weiss Daniel J.8,French Deborah L.4,Gadue Paul4,Murphy George J.59,Mostoslavsky Gustavo39,Kotton Darrell N.129

Affiliation:

1. Boston University Pulmonary Center Boston University School of Medicine, Boston, Massachusetts, USA

2. Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

3. Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

4. Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

5. Section of Hematology and Oncology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA

6. Section of Rheumatology, Department of Medicine, Boston University School of Medicine, Boston, Massachusets, USA

7. Department of Dermatology, Boston University School of Medicine, Boston, Massachusets, USA

8. Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, USA

9. Center for Regenerative Medicine (CReM), Boston University School of Medicine, Boston, Massachusets, USA

Abstract

Abstract The development of methods to achieve efficient reprogramming of human cells while avoiding the permanent presence of reprogramming transgenes represents a critical step toward the use of induced pluripotent stem cells (iPSC) for clinical purposes, such as disease modeling or reconstituting therapies. Although several methods exist for generating iPSC free of reprogramming transgenes from mouse cells or neonatal normal human tissues, a sufficiently efficient reprogramming system is still needed to achieve the widespread derivation of disease-specific iPSC from humans with inherited or degenerative diseases. Here, we report the use of a humanized version of a single lentiviral “stem cell cassette” vector to accomplish efficient reprogramming of normal or diseased skin fibroblasts obtained from humans of virtually any age. Simultaneous transfer of either three or four reprogramming factors into human target cells using this single vector allows derivation of human iPSC containing a single excisable viral integration that on removal generates human iPSC free of integrated transgenes. As a proof of principle, here we apply this strategy to generate >100 lung disease-specific iPSC lines from individuals with a variety of diseases affecting the epithelial, endothelial, or interstitial compartments of the lung, including cystic fibrosis, α-1 antitrypsin deficiency-related emphysema, scleroderma, and sickle-cell disease. Moreover, we demonstrate that human iPSC generated with this approach have the ability to robustly differentiate into definitive endoderm in vitro, the developmental precursor tissue of lung epithelia.

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3